HomeTARA • NASDAQ
add
Protara Therapeutics Inc
Previous close
$5.71
Day range
$5.42 - $5.71
Year range
$2.77 - $7.82
Market cap
288.63M USD
Avg Volume
1.22M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.08M | 33.31% |
Net income | -17.31M | -35.54% |
Net profit margin | — | — |
Earnings per share | -0.38 | 11.63% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 155.55M | -8.65% |
Total assets | 209.47M | 15.44% |
Total liabilities | — | — |
Total equity | 196.41M | — |
Shares outstanding | 54.08M | — |
Price to book | 1.56 | — |
Return on assets | -26.94% | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -17.31M | -35.54% |
Cash from operations | -16.95M | -82.10% |
Cash from investing | -26.91M | -219.59% |
Cash from financing | 80.96M | -17.26% |
Net change in cash | 37.11M | -66.58% |
Free cash flow | — | — |
About
Founded
2006
Website
Employees
46
